CorMedix director Myron Kaplan reports acquisition of $122,000 in common shares
CRMD•CorMedix director Myron Kaplan purchased 25,000 common shares at $4.88 per share, increasing his direct holdings to 256,487 shares.
1. Share purchase
Myron Kaplan purchased 25,000 CorMedix common shares at $4.88 per share. His direct holdings rose to 256,487 shares.




